Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01259440 · ClinicalTrials.gov registry record · Phase 1

Using Telemedicine to Improve Veteran Sleep Apnea Care

A Phase 1 study, sponsored by VA Office of Research and Development.

Completed
Registry status
Phase 1
Development phase
23
Enrollment target

NCT01259440: Completed Phase 1 study, sponsored by VA Office of Research and Development.

NCT01259440 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 23 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (62% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01259440, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
Phase 1
Development phase
23 participants
Enrollment target

Study Summary

Obstructive sleep apnea (OSA) is highly prevalent in the Veteran population given the risk factors of male gender, being overweight, and increasing age. OSA is caused by upper airway obstruction, resulting in arousals from sleep and hypoxia. While continuous positive airway pressure (CPAP) is a highly efficacious treatment for OSA, compliance with treatment is suboptimal. Because research shows that adherence patterns are established early in treatment, we seek to use a technology that enables early and frequent productive interactions between patient and provider.

Primary Outcome

Nightly CPAP adherence measured over the two-month period .

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Video Teleconferencing Care

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2011-08
Est. Completion 2012-05
Phase Phase 1
VA Office of Research and Development

1,668 total trials

What the finished NCT01259440 record still lists

NCT01259440 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (62% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT01259440 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01259440 about?

NCT01259440 is a clinical study titled "Using Telemedicine to Improve Veteran Sleep Apnea Care". Obstructive sleep apnea (OSA) is highly prevalent in the Veteran population given the risk factors of male gender, being overweight, and increasing age. OSA is caused by upper airway obstruction, resulting in arousals from sleep and hypoxia. While continuous positive airway pressure (CPAP) is a high...

What is the current status of trial NCT01259440?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2011-08. Estimated completion is 2012-05.

What interventions are being tested in trial NCT01259440?

The interventions under investigation include: Usual Care (BEHAVIORAL), Video Teleconferencing Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT01259440?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01259440's enrollment target sits among peer trials

23 1596th of 2000 higher than 400 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01259440, the US trial registry maintained by the National Library of Medicine. NCT01259440 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.